Angiogenesis in cancer, vascular, rheumatoid and other disease
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Recent discoveries of endogenous negative regulators of angiogenesis, thrombospondin, angiostatin and glioma-derived angiogenesis inhibitory factor, all associated with neovascularized tumours, suggest a new paradigm of tumorigenesis. It is now helpful to think of the switch to the angiogenic phenotype as a net balance of positive and negative regulators of blood vessel growth. The extent to which the negative regulators are decreased during this switch may dictate whether a primary tumour grows rapidly or slowly and whether metastases grow at all.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Self-citationVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Self-citationTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Self-citationThalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Self-citationPlate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Research works printed but not linked: 9
- Holmgren, L., O'Reilly, M. & Folkman, J. in press (1994).
- Kohn, E. et al. Phase I trial of signal transduction inhibitor, CAI. Proc. Amer. Assoc. Cancer Res. 35,244(1994).
- Folkman, J. Clinical applications of angiogenesis research. New Engl. J. Med. in press (1994).
- Watanabe, H., Nguyen, M., Schizer, M., Li, V., Hayes, D.R., Sallan, S., Folkman, J. Basic fibroblast growth factor in human serum – a prognostic test for breast cancer. Molec. Biol. Cell 3, 324a (1992).
- Szabo, S. et al. Orally administered FGF mutein: Effect on healing of chronic duodenal ulcers in rats. Digestive Disease and Sciences 34, 1323 (1989).
- Hull, M.A., Cullen, D.J.E. & Hawkey, C.J. Basic fibroblast growth factor in gastric ulceration: mucosal levels and therapeutic potential. Gastroenterology 106, A97 (1994).
- Wolfe, M.M. et al. Safety and efficacy of an angiogenic peptide, basic fibroblast growth factor (bFGF) in the treatment of gastroduodenal ulcers: A preliminary report. Gastroenterology 106, A212 (1994).
- Brem, H., Goto, F., Budson, A., Saunders, L. & Folkman, J. Minimal drug resistance after prolonged antiangiogenic therapy with AGM-1470. Surgical Forum XLV, 674–677 (1994).
- O'Reilly, M.S. et al. (unpublished data).
Cited by
Items 701–800 of 1,046
Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis
Emdad, L., Lee, S.-G., Su, Z. Z., Jeon, H. Y., Boukerche, H., Sarkar, D., & Fisher, P. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910936106 · Cited by 194
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia
Berra, E., Milanini, J., Richard, D. E., Le Gall, M., Viñals, F., Gothié, E., Roux, D., Pagès, G., & Pouysségur, J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00423-8 · Cited by 196
Koh, W., Stratman, A. N., Sacharidou, A., & Davis, G. E. (2008) · Methods in Enzymology · doi:10.1016/s0076-6879(08)02005-3 · Cited by 195
Schindler, R., & Mentlein, R. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1477 · Cited by 193
Kato, K., Ogura, T., Kishimoto, A., Minegishi, Y., Nakajima, N., Miyazaki, M., & Esumi, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205737 · Cited by 195
Signal pathway profiling of prostate cancer using reverse phase protein arrays
Grubb, R. L., Calvert, V. S., Wulkuhle, J. D., Paweletz, C. P., Linehan, W. M., Phillips, J. L., Chuaqui, R., Valasco, A., Gillespie, J., Emmert‐Buck, M., et al. (2003) · PROTEOMICS · doi:10.1002/pmic.200300598 · Cited by 194
Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis
Claffey, K. P., & Robinson, G. S. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437469 · Cited by 194
Cao, Y., Ji, W.-R., Qi, P., Rosin, Å., & Cao, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6813 · Cited by 196
Barleon, B., Totzke, F., Herzog, C., Blanke, S., Kremmer, E., Siemeister, G., Marmé, D., & Martiny-Baron, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10382 · Cited by 195
Quantitative analysis of vascular endothelial growth factor in primary breast cancer
Toi, M., Kondo, S., Suzuki, H., Yamamoto, Y., Inada, K., Imazawa, T., Taniguchi, T., & Tominaga, T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960315)77:6<1101::aid-cncr15>3.0.co;2-5 · Cited by 193
PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
Schöder, H., Fury, M., Lee, N., & Kraus, D. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057208 · Cited by 192
Bajaj, S., Asati, V., Singh, J., & Roy, P. P. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.051 · Cited by 187
Technical considerations for studying cancer metastasis in vivo
Welch, D. R. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018477516367 · Cited by 194
Yonekura, H., Sakurai, S., Liu, X., Migita, H., Wang, H., Yamagishi, S.-I., Nomura, M., Abedin, M. J., Unoki, H., Yamamoto, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35172 · Cited by 194
Novel Peptides Selected to Bind Vascular Endothelial Growth Factor Target the Receptor-Binding Site
Fairbrother, W. J., Christinger, H. W., Cochran, A. G., Fuh, G., Keenan, C. J., Quan, C., Shriver, S. K., Tom, J. Y. K., Wells, J. A., & Cunningham, B. C. (1998) · Biochemistry · doi:10.1021/bi981931e · Cited by 190
The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis
You, W.-K., & McDonald, D. M. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.12.833 · Cited by 190
Controlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapy
Fan, T.-P. D., Jagger, R., & Bicknell, R. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88979-8 · Cited by 192
Wu, Y., Hooper, A. T., Zhong, Z., Witte, L., Bohlen, P., Rafii, S., & Hicklin, D. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.21865 · Cited by 192
Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines
Durymanov, M. O., Rosenkranz, A. A., & Sobolev, A. S. (2015) · Theranostics · doi:10.7150/thno.11742 · Cited by 189
Pereira, E. R., Frudd, K., Awad, W., & Hendershot, L. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.507194 · Cited by 191
Roles of Nox1 and other Nox isoforms in cancer development
Kamata, T. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01207.x · Cited by 190
Lee, S.-J., Namkoong, S., Kim, Y.-M., Kim, C.-K., Lee, H., Ha, K.-S., Chung, H.-T., Kwon, Y.-G., & Kim, Y.-M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00113.2006 · Cited by 190
Osada, M., Yatomi, Y., Ohmori, T., Ikeda, H., & Ozaki, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02671-2 · Cited by 190
Roland, C. L., Dineen, S. P., Lynn, K. D., Sullivan, L. A., Dellinger, M. T., Sadegh, L., Sullivan, J. P., Shames, D. S., & Brekken, R. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0280 · Cited by 188
Kallander, L. S., Lu, Q., Chen, W., Tomaszek, T., Yang, G., Tew, D., Meek, T. D., Hofmann, G. A., Schulz-Pritchard, C. K., Smith, W. W., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050408c · Cited by 189
Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer
Zhang, G., Kodani, S., & Hammock, B. D. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.11.003 · Cited by 185
Cai, H., Liu, X., Zheng, J., Xue, Y., Ma, J., Li, Z., Xi, Z., Li, Z., Bao, M., & Liu, Y. (2017) · Oncogene · doi:10.1038/onc.2016.212 · Cited by 189
Medicinal Benefits of Green Tea: Part II. Review of Anticancer Properties
Cooper, R., Morré, D. J., & Morré, D. M. (2005) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2005.11.639 · Cited by 187
Marschall, Z. V., Cramer, T., Höcker, M., Burde, R., Plath, T., Schirner, M., Heidenreich, R., Breier, G., Riecken, E., Wiedenmann, B., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.19578 · Cited by 189
Integrins, angiogenesis and vascular cell survival
Strömblad, S., & Cheresh, D. A. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90176-3 · Cited by 190
Exploring Protein–Protein Interactions with Phage Display
Sidhu, S. S., Fairbrother, W. J., & Deshayes, K. (2003) · ChemBioChem · doi:10.1002/cbic.200390008 · Cited by 190
Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy
Turrini, E., Ferruzzi, L., & Fimognari, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/938475 · Cited by 183
Isolation of endothelial cells from fresh tissues
van Beijnum, J. R., Rousch, M., Castermans, K., van der Linden, E., & Griffioen, A. W. (2008) · Nature Protocols · doi:10.1038/nprot.2008.71 · Cited by 175
Stoeltzing, O., Ahmad, S. A., Liu, W., McCarty, M. F., Wey, J. S., Parikh, A. A., Fan, F., Reinmuth, N., Kawaguchi, M., Bucana, C. D., et al. (2003) · PubMed · Cited by 217
Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan
Ozerdem, U., & Stallcup, W. B. (2004) · Angiogenesis · doi:10.1007/s10456-004-4182-6 · Cited by 187
The p53 gene and its role in human brain tumors
Bögler, O., Su Huang, H. ‐., Kleihues, P., & Cavenee, W. K. (1995) · Glia · doi:10.1002/glia.440150311 · Cited by 187
Ekstrand, A. J., Cao, R., Björndahl, M., Nyström, S., Jönsson-Rylander, A.-C., Hassani, H., Hallberg, B., Nordlander, M., & Cao, Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1135965100 · Cited by 188
Matsumoto, T., Turesson, I., Book, M., Gerwins, P., & Claesson-Welsh, L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200103096 · Cited by 187
VEGF inhibition: insights from preclinical and clinical studies
Crawford, Y., & Ferrara, N. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0675-8 · Cited by 188
Rosen, L. S., Kurzrock, R., Mulay, M., Van Vugt, A., Purdom, M., Ng, C., Silverman, J., Koutsoukos, A., Sun, Y.-N., Bass, M. B., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8170 · Cited by 188
Mandelblatt, J. S., Hadley, J., Kerner, J. F., Schulman, K. A., Gold, K., Dunmore-Griffith, J., Edge, S., Guadagnoli, E., Lynch, J. J., Meropol, N. J., et al. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<561::aid-cncr11>3.0.co;2-a · Cited by 277
Prognostic relevance of altered Fas (CD95)-system in human breast cancer
Mottolese, M., Buglioni, S., Bracalenti, C., Cardarelli, M. A., Ciabocco, L., Giannarelli, D., Botti, C., Natali, P. G., Concetti, A., & Venanzi, F. M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<198::aid-ijc16>3.0.co;2-l · Cited by 105
Mechanisms of tumour metastasis
Meyer, T., & Hart, I. R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10129-0 · Cited by 187
VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma
Maharaj, A. S. R., Walshe, T. E., Saint-Geniez, M., Venkatesha, S., Maldonado, A. E., Himes, N. C., Matharu, K. S., Karumanchi, S. A., & D'Amore, P. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072041 · Cited by 187
Baum, M., Demicheli, R., Hrushesky, W., & Retsky, M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.09.031 · Cited by 190
Xue, Y., Xu, X., Zhang, X.-Q., Farokhzad, O. C., & Langer, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603840113 · Cited by 188
Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis
Rusnati, M., Camozzi, M., Moroni, E., Bottazzi, B., Peri, G., Indraccolo, S., Amadori, A., Mantovani, A., & Presta, M. (2004) · Blood · doi:10.1182/blood-2003-10-3433 · Cited by 187
Jackson, M. W., Bentel, J. M., & Tilley, W. D. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64774-8 · Cited by 188
Baker, C. H., Solórzano, C. C., & Fidler, I. J. (2002) · PubMed · Cited by 196
Vernon, R. B., & Sage, E. H. (1999) · Microvascular Research · doi:10.1006/mvre.1998.2122 · Cited by 185
Zhang, Y., Zhang, N., Dai, B., Liu, M., Sawaya, R., Xie, K., & Huang, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1968 · Cited by 186
Cao, R., Wu, H.-L., Veitonmäki, N., Linden, P., Farnebo, J., Shi, G.-Y., & Cao, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5728 · Cited by 185
Giavazzi, R., Sennino, B., Coltrini, D., Garofalo, A., Dossi, R., Ronca, R., Tosatti, M. P. M., & Presta, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64325-8 · Cited by 185
Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1
Lebovic, D. I., Bentzien, F., Chao, V. A., Garrett, E. N., Meng, Y. G., & Taylor, R. N. (2000) · Molecular Human Reproduction · doi:10.1093/molehr/6.3.269 · Cited by 187
Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors
Akino, T., Hida, K., Hida, Y., Tsuchiya, K., Freedman, D., Muraki, C., Ohga, N., Matsuda, K., Akiyama, K., Harabayashi, T., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090202 · Cited by 183
Yoshiji, H., Kuriyama, S., Ways, D. K., Yoshii, J., Miyamoto, Y., Kawata, M., Ikenaka, Y., Tsujinoue, H., Nakatani, T., Shibuya, M., et al. (1999) · PubMed · Cited by 194
Cianfrocca, M. E., Kimmel, K. A., Gallo, J., Cardoso, T., Brown, M. M., Hudes, G., Lewis, N., Weiner, L., Lam, G. N., Brown, S. C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603171 · Cited by 184
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C., Kellogg, E., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980002x · Cited by 181
Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors
Sund, M., Hamano, Y., Sugimoto, H., Sudhakar, A., Soubasakos, M., Yerramalla, U., Benjamin, L. E., Lawler, J., Kieran, M., Shah, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500180102 · Cited by 179
The role of chemokines in inflammation
Proost, P., Wuyts, A., & Van Damme, J. (1996) · International Journal of Clinical and Laboratory Research · doi:10.1007/bf02602952 · Cited by 182
Marschall, Z. V., Cramer, T., Höcker, M., Finkenzeller, G., Wiedenmann, B., & Rosewicz, S. (2001) · Gut · doi:10.1136/gut.48.1.87 · Cited by 183
A Dynamical Model for the Growth and Size Distribution of Multiple Metastatic Tumors
IWATA, K., KAWASAKI, K., & SHIGESADA, N. (2000) · Journal of Theoretical Biology · doi:10.1006/jtbi.2000.1075 · Cited by 189
Fuh, G., Wu, P., Liang, W.-C., Ultsch, M., Lee, C. V., Moffat, B., & Wiesmann, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507783200 · Cited by 184
Role of the soluble pattern recognition receptor PTX3 in vascular biology
Presta, M., Camozzi, M., Salvatori, G., & Rusnati, M. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00061.x · Cited by 181
Applications of inorganic nanoparticles as therapeutic agents
Kim, T., & Hyeon, T. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/1/012001 · Cited by 180
Fox, S. B., Generali, D. G., & Harris, A. L. (2007) · Breast Cancer Research · doi:10.1186/bcr1796 · Cited by 182
Khodarev, N. N., Yu, J., Labay, E., Darga, T., Brown, C. K., Mauceri, H. J., Yassari, R., Gupta, N., & Weichselbaum, R. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00281 · Cited by 181
Cancer and the Microenvironment
Yaccoby, S., Wezeman, M. J., Henderson, A., Cottler-Fox, M., Yi, Q., Barlogie, B., & Epstein, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1131 · Cited by 181
Mitsuhashi, N., Shimizu, H., Ohtsuka, M., Wakabayashi, Y., Ito, H., Kimura, F., Yoshidome, H., Kato, A., Nukui, Y., & Miyazaki, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50204 · Cited by 183
Podokinesis in endothelial cell migration: role of nitric oxide
Noiri, E., Lee, E., Testa, J., Quigley, J., Colflesh, D., Keese, C. R., Giaever, I., & Goligorsky, M. S. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c236 · Cited by 184
Cyclooxygenase-2 Differentially Directs Uterine Angiogenesis during Implantation in Mice
Matsumoto, H., Ma, W.-G., Daikoku, T., Zhao, X., Paria, B. C., Das, S. K., Trzaskos, J. M., & Dey, S. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203996200 · Cited by 181
Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles
Lee, E. W., Michalkiewicz, M., Kitlinska, J., Kalezic, I., Switalska, H., Yoo, P., Sangkharat, A., Ji, H., Li, L., Michalkiewicz, T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16929 · Cited by 181
MicroRNA regulation in angiogenesis
Caporali, A., & Emanueli, C. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.06.006 · Cited by 179
VEGF Receptor Signaling and Endothelial Function
Kliche, S., & Waltenberger, J. (2001) · IUBMB Life · doi:10.1080/15216540252774784 · Cited by 182
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
Backer, M. V., Gaynutdinov, T. I., Patel, V., Bandyopadhyaya, A. K., Thirumamagal, B. T. S., Tjarks, W., Barth, R. F., Claffey, K., & Backer, J. M. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0161 · Cited by 180
Herbst, R. S., Mullani, N. A., Davis, D. W., Hess, K. R., McConkey, D. J., Charnsangavej, C., O’Reilly, M. S., Kim, H.-W., Baker, C., Roach, J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.102 · Cited by 180
Cascone, I., Napione, L., Maniero, F., Serini, G., & Bussolino, F. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507082 · Cited by 179
Role of copper in tumour angiogenesis—clinical implications
Nasulewicz, A., Mazur, A., & Opolski, A. (2004) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2004.02.004 · Cited by 180
Lamy, S., Lachambre, M.-P., Lord-Dufour, S., & Béliveau, R. (2010) · Vascular Pharmacology · doi:10.1016/j.vph.2010.08.002 · Cited by 178
Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery
Brenner, D. J., Curtis, R. E., Hall, E. J., & Ron, E. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000115)88:2<398::aid-cncr22>3.0.co;2-v · Cited by 618
p38 MAP Kinase—a molecular switch between VEGF‐induced angiogenesis and vascular hyperpermeability
Issbrücker, K., Martin, H. H., Hippenstiel, S., Springmann, G., Voswinckel, R., Gaumann, A., Breier, G., Drexler, H. C. A., Suttorp, N., & Clauss, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0329fje · Cited by 179
Sezer, O., Jakob, C., Eucker, J., Niemoller, K., Gatz, F., Wernecke, K.-D., & Possinger, K. (2001) · European Journal of Haematology · doi:10.1034/j.1600-0609.2001.00348.x · Cited by 181
Kong, H.-L., Hecht, D., Song, W., Kovesdi, I., Hackett, N. R., Yayon, A., & Crystal, R. G. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.6-823 · Cited by 180
Stevenson, W., Cheng, S.-F., Dastjerdi, M. H., Ferrari, G., & Dana, R. (2012) · The Ocular Surface · doi:10.1016/j.jtos.2012.01.005 · Cited by 179
Microparticles in Angiogenesis: Therapeutic Potential
Martinez, M. C., & Andriantsitohaina, R. (2011) · Circulation Research · doi:10.1161/circresaha.110.233049 · Cited by 178
Nonclassic Endogenous Novel Regulators of Angiogenesis
Ribatti, D., Conconi, M. T., & Nussdorfer, G. G. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.2.3 · Cited by 178
Yamamoto, Y., Maeshima, Y., Kitayama, H., Kitamura, S., Takazawa, Y., Sugiyama, H., Yamasaki, Y., & Makino, H. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1831 · Cited by 179
Wnt signaling in the vasculature
Goodwin, A. M., & D'Amore, P. A. (2002) · Angiogenesis · doi:10.1023/a:1021563510866 · Cited by 177
Pathways for aberrant angiogenesis in pancreatic cancer.
Korc, M. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-8 · Cited by 196
Vascular Endothelial Growth Factor-A Promotes Peritumoral Lymphangiogenesis and Lymphatic Metastasis
Björndahl, M. A., Cao, R., Burton, J. B., Brakenhielm, E., Religa, P., Galter, D., Wu, L., & Cao, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2345 · Cited by 178
Interaction between Bevacizumab and Murine VEGF-A: A Reassessment
Yu, L., Wu, X., Cheng, Z., Lee, C. V., LeCouter, J., Campa, C., Fuh, G., Lowman, H., & Ferrara, N. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1175 · Cited by 180
Copper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson's Disease
Brewer, G. J. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020222600712 · Cited by 179
Nair, H. K., Rao, K. V. K., Aalinkeel, R., Mahajan, S., Chawda, R., & Schwartz, S. A. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.1.63-69.2004 · Cited by 179
Lemieux, C., Maliba, R., Favier, J., Théorêt, J.-F., Merhi, Y., & Sirois, M. G. (2005) · Blood · doi:10.1182/blood-2004-09-3531 · Cited by 178
Ramesh, R., Mhashilkar, A. M., Tanaka, F., Saito, Y., Branch, C. D., Sieger, K., Mumm, J. B., Stewart, A., Boquoi, A., Dumoutier, L., et al. (2003) · PubMed · Cited by 178
Nerve growth factor as an angiogenic factor
Nico, B., Mangieri, D., Benagiano, V., Crivellato, E., & Ribatti, D. (2008) · Microvascular Research · doi:10.1016/j.mvr.2007.07.004 · Cited by 178
Laschke, M. W., & Menger, M. D. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm006 · Cited by 180
A Randomized Controlled Trial of Varying Radiation Doses in the Treatment of Choroidal Melanoma
Gragoudas, E. S. (2000) · Archives of Ophthalmology · doi:10.1001/archopht.118.6.773 · Cited by 176
Current biology of VEGF-B and VEGF-C
Olofsson, B., Jeltsch, M., Eriksson, U., & Alitalo, K. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00024-5 · Cited by 179
Zhao, Q., Ishibashi, M., Hiasa, K.-I., Tan, C., Takeshita, A., & Egashira, K. (2004) · Hypertension · doi:10.1161/01.hyp.0000138688.78906.6b · Cited by 177
Metadata
- Authors
- Folkman, J.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- Folkman, Judah
- Venue
- Nature Medicine
- Published
- 1995-01
- Volume
- 1
- Issue
- 1
- Pages
- 27-30
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2000000541
- Semantic Scholar
- 20a719a4d594caa54b1faa591d81eacb3f8d75c1
- Cited by
- 7,627
- References
- 62
- Citations by year
- 2026: 27 · 2025: 47 · 2024: 89 · 2023: 85 · 2022: 104 · 2021: 133 · 2020: 116 · 2019: 147 · 2018: 135 · 2017: 195 · 2016: 186 · 2015: 215 · 2014: 276 · 2013: 300 · 2012: 294
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Vascular Tumors and Angiosarcomas
- Keywords
- angiogenesis, tumor angiogenesis, angiogenic switch, thrombospondin, angiostatin, carcinogenesis, metastasis, vascular disease, rheumatoid arthritis
- MeSH terms
- Animals, Arthritis, Rheumatoid, Eye, Humans, Lymphokines, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Peptide Fragments, Plasminogen, Psoriasis, Time Factors, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Angiostatins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.